Results 141 to 150 of about 26,499 (240)

Lysosomal cysteine proteinases as mediators of inflammation and tumor spread [PDF]

, 1992
Assfalg-Machleidt, Irmgard, Jochum, Marianne, Jänicke, F., Machleidt, W., Schmitt, M.   +4 more
core   +1 more source

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Clinical Pharmacology: Advances and Applications, 2018
Felix Oh,1 Deborah Todhunter,1 Elizabeth Taras,1 Daniel A Vallera,1,2 Antonella Borgatti2,3 1Department of Therapeutic Radiology-Radiation Oncology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; 2Animal Cancer Care and Research ...
Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A   +4 more
doaj  

Urokinase Plasminogen Activator Surface Receptor [PDF]

, 2020
openaire   +1 more source

Plasminogen activator, urokinase receptor (PLAUR; UPAR) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Beyond Fibrinolysis: Urokinase Plasminogen Activator as an Early Regulator of Obesity. [PDF]

Arterioscler Thromb Vasc Biol
Torrente D, Strickland S.
europepmc   +1 more source

Maternal soluble urokinase plasminogen activator receptor levels in intrahepatic cholestasis of pregnancy: a predictor of neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Aktaş BA, Agaoglu Z, Peker BN, Başaran E, Orhan N, Özdal BB, Şahin D.   +6 more
europepmc   +1 more source

Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations. [PDF]

Front Immunol
Napolitano F, Mormile I, Mignogna G, de Paulis A, Rossi FW, Montuori N.   +5 more
europepmc   +1 more source

Integrin α5β1 mediates the inhibitory effects of vasoinhibin on angiogenesis and vascular permeability. [PDF]

J Biol Chem
Zamora M, Clapp C, Martínez de la Escalera G, Robles JP.   +3 more
europepmc   +1 more source

Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. [PDF]

Med Sci Monit
Wang H, Huang C.
europepmc   +1 more source

The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer. [PDF]

Rev Assoc Med Bras (1992)
Gülüm C, Eroğlu P, Tanrıverdi R, Bozlu M.   +3 more
europepmc   +1 more source